✦ LIBER ✦

Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? : Yes: Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast

✍ Scribed by Thomas A. Buchholz; Bruce G. Haffty; Jay R. Harris

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 94 KB
Volume: 95
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.20711

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Should all patients undergoing breast co

Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? : No: One size does not fit all: An argument against the routine use of radiation therapy for all patients with ductal carcinoma in situ of the breast who elect breast conservation

✍ Melvin J. Silverstein; Michael D. Lagios 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Margin width as a determinant of local c

Margin width as a determinant of local control with and without radiation therapy for ductal carcinoma in situ (DCIS) of the breast

✍ Andrew C. Neuschatz; Thomas DiPetrillo; Homa Safaii; David Lowther; Marcia Landa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 98 KB

In order to assess the utility of margin width in relation to other histopathologic features as a determinant of local control in ductal carcinoma in situ (DCIS) of the breast, we retrospectively examined the treatment of 109 breasts treated with (n ‫؍‬ 54) or without adjuvant radiotherapy (n ‫؍‬ 55

The relation between the presence and ex

The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy

✍ Anthony L. Abner; James L. Connolly; Abram Recht; Bruce Bornstein; Asa Nixon; St 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

## Background: When found in an otherwise benign biopsy, lobular carcinoma in situ (lcis) has been associated with an increased risk of development of a subsequent invasive breast carcinoma. however, the association between lcis and the risk of subsequent local recurrence in patients with infiltrat